Enovis (ENOV) Shares Outstanding (2010 - 2026)
Enovis' (ENOV) quarterly Shares Outstanding (Entity) came in at $57.6 million in Q2 2026, up 0.76% year-on-year from $57.1 million in Q2 2025, and up 0.63% on a QoQ basis from $57.2 million in Q4 2025.
Enovis (ENOV) Shares Outstanding (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Shares Outstanding (Entity) data on file, last reported at $57.6 million in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 0.76% year-over-year to $57.6 million in Q2 2026; TTM through Apr 2026 was $57.6 million, a 0.76% increase from a year earlier, with the FY2025 full-year figure at $57.2 million, up 2.36% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $57.6 million, up from $57.2 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for ENOV reached as high as $57.6 million in Q2 2026 and fell as low as $54.0 million in Q2 2022.
- Historically, Shares Outstanding (Entity) has averaged $55.4 million across 5 years, with a median of $54.8 million in 2024.
- Across the five-year window, Shares Outstanding (Entity) advanced 19.54% in 2022 and advanced 0.61% in 2024, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $54.2 million in 2022, then rose by 0.68% to $54.6 million in 2023, then increased by 2.34% to $55.9 million in 2024, then advanced by 2.36% to $57.2 million in 2025, then rose by 0.63% to $57.6 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $57.6 million in Q2 2026, $57.2 million in Q4 2025, and $57.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 57.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 57.31 Mn |
| Dec 31, 2025 | 57.07 Mn |
| Oct 3, 2025 | 57.17 Mn |
| Jul 4, 2025 | 57.13 Mn |
| Apr 4, 2025 | 56.79 Mn |
| Dec 31, 2024 | 55.28 Mn |
| Sep 27, 2024 | 55.67 Mn |
| Jun 28, 2024 | 54.86 Mn |
| Mar 29, 2024 | 54.69 Mn |
| Dec 31, 2023 | 54.49 Mn |
| Sep 29, 2023 | 54.55 Mn |
| Jun 30, 2023 | 54.51 Mn |
| Mar 31, 2023 | 54.33 Mn |
| Dec 31, 2022 | 54.07 Mn |
| Sep 30, 2022 | 54.14 Mn |
| Jul 1, 2022 | 54.08 Mn |
| Apr 1, 2022 | 53.87 Mn |
| Dec 31, 2021 | 51.14 Mn |
| Oct 1, 2021 | 53.03 Mn |
| Jul 2, 2021 | 51.29 Mn |